James O. Jones - Concepedia

Author

James O. Jones

University of Cambridge ORCID

Also Known As

J.O. Jones, James Jones, James O Jones, James O. Jones, James Owain Jones, Jones, James O., Jones, James Owain

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

University of Cambridge Cancer Research UK Addenbrooke's Hospital MRC Cancer Unit Cold Spring Harbor Laboratory

About

James O. Jones is an author at University of Cambridge specializing in tumor microenvironment, medicine, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	1.2K
2	Cell Biology	2	2	1.2K
3	Engineering	1	1	31
4	Immunology	1	1	1.1K
5	Pathology	1	1	31

James O. Jones

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti–PD-L1 immunotherapy in pancreatic cancer Christine Feig, James O. Jones, Matthew Kraman, Proceedings of the National Academy of Sciences	2013	1.9K
Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein–α Matthew Kraman, Paul Bambrough, James N. Arnold, Science Fap-expressing CellsImmunologyImmune RegulationImmunoeditingImmunologic Mechanism	2010	1.1K
Depletion of stromal cells expressing fibroblast activation protein-α from skeletal muscle and bone marrow results in cachexia and anemia Edward W. Roberts, Andrew Deonarine, James O. Jones, The Journal of Experimental Medicine	2013	396
Stromal-driven and Amyloid β-dependent induction of neutrophil extracellular traps modulates tumor growth Hafsa Munir, James O. Jones, Tobias Janowitz, Nature Communications	2021	155
A Phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA) Grant D. Stewart, Sarah J. Welsh, Stephan Ursprung, British Journal of Cancer	2022	60
A Single-Agent Dual-Specificity Targeting of FOLR1 and DR5 as an Effective Strategy for Ovarian Cancer Gururaj Shivange, Karol Urbanek, Piotr Przanowski, Cancer Cell Effective StrategyDrug TargetingMedicineCancer BiologyTumor Targeting	2018	47
A purine metabolic checkpoint that prevents autoimmunity and autoinflammation Svetlana Saveljeva, Gavin W. Sewell, Katharina Ramshorn, Cell Metabolism	2022	45
TOX3 Mutations in Breast Cancer James O. Jones, Suet‐Feung Chin, Li-An Wong-Taylor, PLoS ONE Breast OncologyEngineeringSomatic VariantTumor HeterogeneityMedicine	2013	31

Page 1